Solventum

Solventum emerged in 2024 as an independent company following its spin-off from 3M, bringing decades of healthcare product innovation into a focused standalone entity. The company operates across multiple healthcare domains including medical devices, oral care, health information technology, and purification/filtration systems for biopharmaceutical manufacturing.

Their product portfolio spans advanced wound care solutions like V.A.C. Therapy and Prevena closed incision systems, dental restoratives and orthodontic products including Filtek materials, health information management software for clinicians and coders, and filtration technologies for life sciences manufacturing. In early 2025, Solventum expanded its wound care capabilities through the acquisition of Acera Surgical and its Restrata regenerative technology.

The company maintains a global presence with operations across North America, Europe, Asia-Pacific, and other regions. Solventum earned Diamond Level certification from the Healthcare Industry Resilience Collaborative in 2025, demonstrating supply chain strength for critical healthcare products.

Organizations should consider Solventum when seeking established medical products with extensive clinical validation and regulatory clearances. The company's strength lies in providing physical healthcare products and associated health information systems rather than custom technology development services.

Expect engagement through product procurement and implementation support rather than custom software projects. The company's global supply chain infrastructure and HIRC Diamond certification make it suitable for organizations requiring reliable access to critical medical devices and materials.

Solventum operates exclusively in healthcare across medical, dental, health IT, and life sciences sectors. Their medical division serves hospitals with wound care, infection prevention, and surgical products. The oral care division provides dental restoratives, orthodontic solutions, and practice management tools for dental professionals.

Health information technology offerings include documentation, coding, and clinical decision support systems designed for healthcare workflows. Their purification and filtration division specifically serves biopharmaceutical manufacturing with solutions for drug development and production processes requiring stringent regulatory compliance.

Large hospital systems and healthcare networks requiring standardized medical devices with proven clinical outcomes. Dental and orthodontic practices seeking established materials backed by extensive research. Biopharmaceutical manufacturers needing validated filtration systems for regulatory compliance in drug production.